Alkermes plc. Earnings Per Share, Basic and Diluted
Alkermes plc. (ALKS) reported Earnings Per Share, Basic and Diluted of -$0.22 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-04-27.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-04-27
- Alkermes plc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.22.
- Alkermes plc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.18.
- Alkermes plc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was $0.01.
- Alkermes plc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.14.
- Alkermes plc. earnings per share, basic and diluted for fiscal 2021 was -$0.30.
- Alkermes plc. earnings per share, basic and diluted for fiscal 2020 was -$0.70.
- Alkermes plc. earnings per share, basic and diluted for fiscal 2019 was -$1.25.
- Alkermes plc. earnings per share, basic and diluted for fiscal 2018 was -$0.90.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.22 10-Q · filed 2022-04-27 | |||
| 2021-12-31 | -$0.30 10-K · filed 2022-02-16 | |||
| 2021-09-30 | -$0.18 10-Q · filed 2021-10-27 | -$0.31 10-Q · filed 2021-10-27 | ||
| 2021-06-30 | $0.01 10-Q · filed 2021-07-28 | -$0.13 10-Q · filed 2021-07-28 | ||
| 2021-03-31 | -$0.14 10-Q · filed 2022-04-27 | |||
| 2020-12-31 | -$0.70 10-K · filed 2022-02-16 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-10-27 | -$0.43 10-Q · filed 2021-10-27 | ||
| 2020-06-30 | -$0.19 10-Q · filed 2021-07-28 | -$0.43 10-Q · filed 2021-07-28 | ||
| 2020-03-31 | -$0.24 10-Q · filed 2021-04-28 | |||
| 2019-12-31 | -$1.25 10-K · filed 2022-02-16 | |||
| 2019-09-30 | -$0.34 10-Q · filed 2020-10-29 | -$1.22 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | -$0.27 10-Q · filed 2020-07-29 | -$0.88 10-Q · filed 2020-07-29 | ||
| 2019-03-31 | -$0.62 10-Q · filed 2020-04-29 | |||
| 2018-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$0.28 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$0.49 derived: net income ÷ weighted average shares · filed 2021-02-11 | -$0.90 10-K · filed 2021-02-11 |
| 2018-09-30 | -$0.22 10-Q · filed 2019-10-23 | -$0.43 derived: net income ÷ weighted average shares · filed 2019-10-23 | -$0.84 10-Q · filed 2019-10-23 | -$0.90 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2018-06-30 | -$0.21 10-Q · filed 2019-07-25 | -$0.61 10-Q · filed 2019-07-25 | -$0.68 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.92 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2018-03-31 | -$0.40 10-Q · filed 2019-04-25 | -$0.47 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.71 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.99 derived: net income ÷ weighted average shares · filed 2020-02-13 |
| 2017-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.30 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.58 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$1.03 10-K · filed 2020-02-13 |
| 2017-09-30 | -$0.24 10-Q · filed 2018-10-23 | -$0.52 derived: net income ÷ weighted average shares · filed 2018-10-23 | -$0.97 10-Q · filed 2018-10-23 | -$1.11 derived: net income ÷ weighted average shares · filed 2019-02-15 |
| 2017-06-30 | -$0.28 10-Q · filed 2018-07-26 | -$0.73 10-Q · filed 2018-07-26 | -$0.87 derived: net income ÷ weighted average shares · filed 2019-02-15 | -$1.28 derived: net income ÷ weighted average shares · filed 2019-02-15 |
| 2017-03-31 | -$0.45 10-Q · filed 2018-04-26 | -$0.59 derived: net income ÷ weighted average shares · filed 2019-02-15 | -$1.00 derived: net income ÷ weighted average shares · filed 2019-02-15 | -$1.32 derived: net income ÷ weighted average shares · filed 2019-02-15 |
| 2016-12-31 | -$0.14 derived: net income ÷ weighted average shares · filed 2019-02-15 | -$0.55 derived: net income ÷ weighted average shares · filed 2019-02-15 | -$0.86 derived: net income ÷ weighted average shares · filed 2019-02-15 | -$1.38 10-K · filed 2019-02-15 |
| 2016-09-30 | -$0.41 10-Q · filed 2017-10-26 | -$0.73 derived: net income ÷ weighted average shares · filed 2017-10-26 | -$1.24 10-Q · filed 2017-10-26 | -$1.70 derived: net income ÷ weighted average shares · filed 2018-02-16 |
| 2016-06-30 | -$0.31 10-Q · filed 2017-07-27 | -$0.82 10-Q · filed 2017-07-27 | -$1.29 derived: net income ÷ weighted average shares · filed 2018-02-16 | -$1.83 derived: net income ÷ weighted average shares · filed 2018-02-16 |
| 2016-03-31 | -$0.51 10-Q · filed 2017-04-27 | -$0.97 derived: net income ÷ weighted average shares · filed 2018-02-16 | -$1.52 derived: net income ÷ weighted average shares · filed 2018-02-16 | -$1.83 derived: net income ÷ weighted average shares · filed 2018-02-16 |
| 2015-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2018-02-16 | -$1.00 derived: net income ÷ weighted average shares · filed 2018-02-16 | -$1.31 derived: net income ÷ weighted average shares · filed 2018-02-16 | -$1.52 10-K · filed 2018-02-16 |
| 2015-09-30 | -$0.54 10-Q · filed 2016-11-02 | -$0.85 derived: net income ÷ weighted average shares · filed 2016-11-02 | -$1.06 10-Q · filed 2016-11-02 | -$0.86 derived: net income ÷ weighted average shares · filed 2017-02-17 |
| 2015-06-30 | -$0.31 10-Q · filed 2016-07-28 | -$0.52 10-Q · filed 2016-07-28 | -$0.31 derived: net income ÷ weighted average shares · filed 2017-02-17 | -$0.58 derived: net income ÷ weighted average shares · filed 2017-02-17 |
| 2015-03-31 | -$0.21 10-Q · filed 2016-04-28 | -$0.00 derived: net income ÷ weighted average shares · filed 2017-02-17 | -$0.27 derived: net income ÷ weighted average shares · filed 2017-02-17 | |
| 2014-12-31 | $0.21 derived: net income ÷ weighted average shares · filed 2017-02-17 | -$0.06 derived: net income ÷ weighted average shares · filed 2017-02-17 | -$0.21 10-K · filed 2017-02-17 | |
| 2014-09-30 | -$0.27 10-Q · filed 2015-10-29 | -$0.42 10-Q · filed 2015-10-29 | ||
| 2014-03-31 | -$0.17 10-Q · filed 2015-04-30 | |||
| 2013-12-31 | $0.13 derived: net income ÷ weighted average shares · filed 2016-02-25 | |||
| 2012-06-30 | $0.17 10-Q · filed 2012-07-26 | |||
| 2011-06-30 | -$0.14 10-Q · filed 2012-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |